Biotech

All Articles

Gene publisher Volume giving up 131 employees

.Simply days after gene publisher Volume Biosciences revealed secret working slices, a clearer pictu...

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Rehab is actually laying off an one-fourth of its staff as the oncology biotech lessen its p...

J &amp J declare FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten another measure towards realizing a profit on its $6.5 billion nipo...

Gain's stage 1 gain leads method to verify Parkinson's medicine's worth

.Increase Rehabs has set its own direct confirming the efficiency of its Parkinson's ailment therapy...

Actinogen files new phase 2 data to recover depression medicine

.Actinogen Medical's hopes-- and also supply price-- have rebounded a little from earlier this month...

Pfizer as well as Flagship add Ratio to multibillion-dollar equation

.Flagship Pioneering as well as Pfizer have added Quotient in to their 10-program relationship, inki...

Bayer pens $547M pact to push limits of noncoding RNA

.Bayer managers were eager to anxiety to Intense this summer season that the German pharma giant's a...

UK unveils programs to release 18 brand-new medical test centers

.In the middle of a yearslong scientific test downtrend in the U.K., a brand new public-private alli...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology study device

.Following the announcement of a huge unemployment shot in April and a significant restructuring cam...

Neurocrine's KarXT opponent hits in phase 2-- yet only at reduced dose

.Neurocrine Biosciences has actually accomplished its hoped-for profile page in a period 2 mental il...